Drug Approval | February 17, 2024
Lupin receives approval from USFDA for Minzoya
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Subscribe To Our Newsletter & Stay Updated
